The biopharma industry loses approximately $35 billion annually due to failures in temperature-controlled logistics,” he ...

If a pharmaceutical manufacturer is unable ... SVP of manufacturer and replenishment operations, and Gregg Gorniak, VP of ...

Creating contingency plans against geopolitical uncertainty was a key theme at the 2024 Outsourcing in Clinical Trials and ...

Bachem's Pascal Degen explains the challenges faced by CDMOs in a volatile, uncertain, complex and ambiguous (VUCA) world.

The Weybridge, United Kingdom-headquartered group announced in late September that it plans to raise its stake in Tianjin ...